Company news

Hikma Pharmaceuticals PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Hikma and Richter sign agreement for cariprazine

July 25, 2019

Hikma and Civica Rx sign long-term agreement

July 23, 2019

Hikma launches 100th injectable medicine in US

May 1, 2019

Hikma establishes partnership with Melinta in MENA

February 28, 2019

Hikma launches Mitomycin for Injection

January 29, 2019

Hikma announces agreement with Sciecure Pharma

January 3, 2019

Hikma launches Clobazam

December 10, 2018

Hikma announces injectable licensing agreement

November 27, 2018

Hikma launches Triazolam Tablets

November 19, 2018

Hikma announces agreement with Vectura

November 8, 2018

Hikma enters licensing partnership with Perrigo

July 9, 2018

Hikma appoints Chief Transformation Officer

June 4, 2018

Hikma launches Methylergonovine Maleate Tablets

May 30, 2018

AGM Results

May 18, 2018

Hikma launches Methotrexate Injection

May 3, 2018

Hikma expands licensing agreement with Rovi

April 24, 2018

Hikma launches Dexrazoxane for Injection

April 20, 2018

Hikma launch-Palonosetron Hydrochloride Injection

March 29, 2018

Hikma has launched Ritonavir Tablets USP

March 20, 2018

Update status on ANDA for generic Advair Diskus®

March 12, 2018

Sigurdur Olafsson appointed CEO of Hikma

February 20, 2018

Hikma Appoints Dr. Surendera Tyagi

January 15, 2018

Hikma reaches licensing agreement with Celltrion

December 19, 2017

Hikma- Dihydroergotamine Mesylate Injection, USP

December 13, 2017

Hikma Ventures- $20.5m Series C round for Prognos

November 30, 2017

Announcement

November 28, 2017

Hikma Ventures invests in Biolinq

November 27, 2017

Hikma Acquires Products from Boehringer Ingelheim

November 14, 2017

Hikma launches Flucytosine Capsules USP in US

November 3, 2017

Hikma launches Pantoprazole Sodium for Injection

October 30, 2017

Hikma announces licensing agreement with Takeda

August 17, 2017

Leadership and Structural Changes to US Business

June 26, 2017

Hikma update on ANDA for generic Advair Diskus

May 11, 2017

Change of Registered Address

May 8, 2017

Change of Registered Office

May 3, 2017

Hikma enters into settlement agreement with Jazz

April 6, 2017

Hikma launches Desvenlafaxine Succinate Tablets

March 10, 2017

Licensing agreement with Orion for Easyhaler®

February 13, 2017

Hikma receives approval for Sodium Oxybate

January 18, 2017

Board appointment and succession

September 20, 2016

Regulatory approval of Hikma's colchicine upheld

July 21, 2016

Launch of Generic Xeloda® Tablets in the US

July 20, 2016

Further re Colchicine Litigation

May 19, 2016

AGM Statement

May 12, 2016

Doc re. Bond Guarantor Group

May 6, 2016

Update on ANDA for Generic Advair Diskus®

April 8, 2016

Annual Information Update

April 7, 2016

Blocklisting Interim Review

April 6, 2016

Roxane Acquisition Close

February 29, 2016

EGM Statement

February 19, 2016

← Newer news releases · Older news releases →

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 50 decks. Every deck is listed under its year.